Status: Recruiting
A Study of [177Lu] Lu-PSMA-XT Injection in Patients With Metastatic Prostate Cancer
This was a multicenter, open-label, phase I study to evaluate the safety, tolerability, radiation dosimetry and efficacy of \[177Lu\] Lu-PSMA-XT injection in patients with metastatic prostate cancer .
Participants needed: 36
Trial details
Phase: Phase 1Age: 18+Biological sex: MaleType: InterventionalSponsor: Jinming ZhangUpdated: Jul 31, 2025Locations: 3
Eligibility criteria
Patients must have the ability to understand and sign an approved informed conse... [+10]
Previous treatment with any of the following within 6 months of enrollment: Stro... [+6]